Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Reduction of cyclooxygenase-2 in the blockage of ovulation

Reproductive Toxicology

Volumn 16, Issue 3, 2002, Pages 299-307

  Mizuyachi, Kaori ^a,b   Son, Deok Soo ^a,b   Rozman, Karl K ^b,c   Terranova, Paul F ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

AhR; COX 2; CYP1A1; Granulosa cell; Immature rat; Ovary; Ovulation; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANDROSTENEDIONE; AROMATIC HYDROCARBON RECEPTOR; CHORIONIC GONADOTROPIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P 450 CYP1A1; CYTOCHROME P450 1A1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHOXYRESORUFIN DEETHYLASE; GLUCOCORTICOID RECEPTOR; ISOENZYME; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTAGLANDIN SYNTHASE; RIBOSOMAL PROTEIN L19; RIBOSOME PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR; UROKINASE; MEMBRANE PROTEIN; PTGS1 PROTEIN, RAT; RPL19 PROTEIN, RAT;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; ENZYMOLOGY; FEEDING; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARY; OVARY FOLLICLE DEVELOPMENT; OVULATION; OVULATION INHIBITION; POLLUTANT; RAT; RAT STRAIN; RECEPTOR UPREGULATION; REPRODUCTION; SEXUAL MATURATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMAL; CHORIONIC GONADOTROPIN; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; ISOENZYMES; OVARY; OVULATION; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RIBOSOMAL PROTEINS; RNA, MESSENGER; SEX MATURATION; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTORS; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEXUAL MATURATION;

EQUIDAE; ZEA MAYS;

EID: 0036558456     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(02)00024-2     Document Type: Article

References (65)

1. Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons
2. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms, and animal models
3. Presence of dioxins in human follicular fluid: Their possible stage-specific action on the development of preimplantation mouse embryos
4. Reproductive effects of 2,3.7,8tetrachlorodibenzo-p-dioxin (TCDD) in female rats: Ovulation, hormonal regulation, and possible mechanism(s)
5. Toxic equivalency (TEQ) of polychlorinated dibenzo-p-dioxins (PCDDs) in an ovulation model: Validation of the TEQ concept for endocrine disruption
6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) blocks ovulation by a direct action on the ovary without alteration of ovarian steroidogenesis: Lack of a direct effect on ovarian granulosa and thecal-interstitial cell steroidogenesis in vitro
7. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on estrous cyclicity and ovulation in female Sprague-Dawley rats
8. Prenatal TCDD and predisposition to mammary cancer in the rat
9. Gonadotropinreleasing hormone (GnRH) partially reverses the inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on ovulation in the immature gonadotropin-treated rat
10. Interaction of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in an ovulation model: Evidence for systemic potentiation and local ovarian effects
11. 2,3,7,8-Tetrachlorodibenzo-pdioxin (TCDD) increases release of luteinizing hormone and follicle-stimulating hormone from the pituitary of immature female rats in vivo and in vitro
12. In utero and lactational exposure of female Holtzman rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Modulation of the estrogen signal
13. Regulation of the aromatic hydrocarbon receptor (AHR) by in utero and lactational exposure to 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD)
14. Mechanism of toxic action of 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) in cultured human luteinizing granulosa cells
15. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinizing granulosa cells
16. The aryl hydrocarbon receptor complex
17. Ah receptor signaling pathways
18. Aryl hydrocarbon receptor-mediated signal transduction
19. Functional role of estrogen metabolism in target cells: Review and perspectives
20. Estrogen receptor and aromatic hydrocarbon receptor in the primate ovary
21. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17βestradial metabolism in human breast cancer cells
22. Antiestrogenic activities of alternate-substituted polychlorinated dibenzofurans in MCF-7 human breast cancer cells
23. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine epidermal growth factor receptor binding activity and gene expression
24. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells
25. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists
26. Regulation of the plasminogen activator system in the ovary
27. Control of steroidogenesis in the preovulatory rat follicle
28. Multiple female reproductive failures in cyclooxygenase 2-deficient mice
29. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta
30. Relationship between the preovulatory luteinizing hormone (LH) surge and androstenedione synthesis of preantral follicles in the cyclic hamster: Detection by in vitro response to LH
31. Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts
32. Regulation of the progesterone receptor gene by gonadotropins and cyclic adenosine 3′,5′-monophosphate in rat granulosa cells
33. Detection and analysis of proteins expressed from cloned genes
34. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle
35. Regulation of prostaglandin-endoperoxide synthase 2 messenger ribonucleic acid expression in mouse granulosa cells during ovulation
36. Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation
37. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: A randomized double-blind study
38. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice
39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin decreases responsiveness of the hypothalamus to estradiol as a feedback inducer of preovulatory gonadotropin secretion in the immature gonadotropin-primed rat
40. Ovulation: A multi-gene, multi-step process
41. Luteinizing hormone induces prostaglandin endoperoxide synthase-2 and luteinization in vitro by A-kinase and C-kinase pathways
42. The selective prostaglandin endoperoxide synthase-2 inhibitor. NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat
43. Impaired ovulation by 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) in immature rats treated with equine chorionic gonadotropin
44. Alterations in follicle development, steroidogenesis, and gonadotropin receptor binding in a model of ovulatory blockade
45. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization
46. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases steady-state estrogen receptorbeta mRNA levels after CYP1A1 and CYP1B1 induction in rat granulosa cells in vitro (1)
47. Toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats including placental and lactational transfer to fetuses and neonates
48. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR
49. Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes
50. The human membrane progesterone receptor gene: Genomic structure and promoter analysis
51. ARNT-deficient mice and placental differentiation
52. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2
53. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats
54. Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone
55. Autoregulation of glucocorticoid receptor gene expression
56. Enhancement of phosphorylation and transcriptional activity of the glucocorticoid receptor in human synovial fibroblasts by nimesulide, a preferential cyclooxygenase 2 inhibitor
57. Sustained but not repeated acute elevation of cortisol impaired the luteinizing hormone surge, estrus, and ovulation in gilts
58. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: Evidence for glucocorticoid receptor-mediated regulation
59. Glucocorticoid receptor-mediated post-ceramide inhibition of the interleukin-1beta-dependent induction of ovarian prostaglandin endoperoxide synthase-2 in rats
60. The hypothalamic-pituitary-adrenal axis and the female reproductive system
61. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activators
62. Studies of mice lacking plasminogen activator gene function suggest that plasmin production prior to ovulation exceeds the amount needed for optimal ovulation efficiency
63. Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line
64. TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells
65. Expression of dioxin-responsive genes in human endometrial cells in culture